Literature DB >> 29794226

The Immunoimaging Toolbox.

Aaron T Mayer1, Sanjiv S Gambhir2,3.   

Abstract

The recent clinical success of cancer immunotherapy has renewed interest in the development of tools to image the immune system. In general, immunotherapies attempt to enable the body's own immune cells to seek out and destroy malignant disease. Molecular imaging of the cells and molecules that regulate immunity could provide unique insight into the mechanisms of action, and failure, of immunotherapies. In this article, we will provide a comprehensive overview of the current state-of-the-art immunoimaging toolbox with a focus on imaging strategies and their applications toward immunotherapy.
© 2018 by the Society of Nuclear Medicine and Molecular Imaging.

Entities:  

Keywords:  cell tracking; immune imaging; immunotherapy; molecular imaging; oncology; radioimmunoimaging

Mesh:

Year:  2018        PMID: 29794226      PMCID: PMC6071502          DOI: 10.2967/jnumed.116.185967

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  112 in total

1.  Effective migration of antigen-pulsed dendritic cells to lymph nodes in melanoma patients is determined by their maturation state.

Authors:  I Jolanda M De Vries; Daniëlle J E B Krooshoop; Nicole M Scharenborg; W Joost Lesterhuis; J Heleen S Diepstra; Goos N P Van Muijen; Simon P Strijk; Theo J Ruers; Otto C Boerman; Wim J G Oyen; Gosse J Adema; Cornelis J A Punt; Carl G Figdor
Journal:  Cancer Res       Date:  2003-01-01       Impact factor: 12.701

2.  Reporter gene imaging of targeted T cell immunotherapy in recurrent glioma.

Authors:  Khun Visith Keu; Timothy H Witney; Shahriar Yaghoubi; Jarrett Rosenberg; Anita Kurien; Rachel Magnusson; John Williams; Frezghi Habte; Jamie R Wagner; Stephen Forman; Christine Brown; Martin Allen-Auerbach; Johannes Czernin; Winson Tang; Michael C Jensen; Behnam Badie; Sanjiv S Gambhir
Journal:  Sci Transl Med       Date:  2017-01-18       Impact factor: 17.956

3.  Use of insulin to improve [18 F]fluorodeoxyglucose labelling and retention for in vivo positron emission tomography imaging of monocyte trafficking.

Authors:  J-Y Paik; K-H Lee; S-S Byun; Y S Choe; B-T Kim
Journal:  Nucl Med Commun       Date:  2002-06       Impact factor: 1.690

4.  Rapid PD-L1 detection in tumors with PET using a highly specific peptide.

Authors:  Samit Chatterjee; Wojciech G Lesniak; Michelle S Miller; Ala Lisok; Emilia Sikorska; Bryan Wharram; Dhiraj Kumar; Matthew Gabrielson; Martin G Pomper; Sandra B Gabelli; Sridhar Nimmagadda
Journal:  Biochem Biophys Res Commun       Date:  2016-12-24       Impact factor: 3.575

5.  Immuno-PET of Murine T Cell Reconstitution Postadoptive Stem Cell Transplantation Using Anti-CD4 and Anti-CD8 Cys-Diabodies.

Authors:  Richard Tavaré; Melissa N McCracken; Kirstin A Zettlitz; Felix B Salazar; Tove Olafsen; Owen N Witte; Anna M Wu
Journal:  J Nucl Med       Date:  2015-05-07       Impact factor: 10.057

6.  A novel engineered anti-CD20 tracer enables early time PET imaging in a humanized transgenic mouse model of B-cell non-Hodgkins lymphoma.

Authors:  Arutselvan Natarajan; Benjamin J Hackel; Sanjiv Sam Gambhir
Journal:  Clin Cancer Res       Date:  2013-10-04       Impact factor: 12.531

7.  Macrophage endocytosis of superparamagnetic iron oxide nanoparticles: mechanisms and comparison of ferumoxides and ferumoxtran-10.

Authors:  Isabelle Raynal; Philippe Prigent; Sophie Peyramaure; Abderrahim Najid; Cécile Rebuzzi; Claire Corot
Journal:  Invest Radiol       Date:  2004-01       Impact factor: 6.016

8.  Predicting the response to CTLA-4 blockade by longitudinal noninvasive monitoring of CD8 T cells.

Authors:  Mohammad Rashidian; Jessica R Ingram; Michael Dougan; Anushka Dongre; Katherine A Whang; Camille LeGall; Juan J Cragnolini; Brian Bierie; Monica Gostissa; James Gorman; Gijsbert M Grotenbreg; Atul Bhan; Robert A Weinberg; Hidde L Ploegh
Journal:  J Exp Med       Date:  2017-06-30       Impact factor: 14.307

Review 9.  Advances in Monitoring Cell-Based Therapies with Magnetic Resonance Imaging: Future Perspectives.

Authors:  Ethel J Ngen; Dmitri Artemov
Journal:  Int J Mol Sci       Date:  2017-01-19       Impact factor: 6.208

10.  Molecular imaging of lymphoid organs and immune activation by positron emission tomography with a new [18F]-labeled 2'-deoxycytidine analog.

Authors:  Caius G Radu; Chengyi J Shu; Evan Nair-Gill; Stephanie M Shelly; Jorge R Barrio; Nagichettiar Satyamurthy; Michael E Phelps; Owen N Witte
Journal:  Nat Med       Date:  2008-06-08       Impact factor: 53.440

View more
  21 in total

1.  Predicting PD-1/PD-L1 status in bladder cancer with 18F-FDG PET?

Authors:  Emily B Ehlerding; Xiaoli Lan; Weibo Cai
Journal:  Eur J Nucl Med Mol Imaging       Date:  2018-12-11       Impact factor: 9.236

2.  The Production, Quality Control, and Characterization of ZED8, a CD8-Specific 89Zr-Labeled Immuno-PET Clinical Imaging Agent.

Authors:  Herman Gill; Richard Seipert; Vincent M Carroll; Alexandra Gouasmat; Jian Yin; Annie Ogasawara; Isabella de Jong; Minh Michael Phan; Xiangdan Wang; Jihong Yang; Ohad Ilovich; Jan Marik; Simon-Peter Williams
Journal:  AAPS J       Date:  2020-01-03       Impact factor: 4.009

Review 3.  Visualizing T-Cell Responses: The T-Cell PET Imaging Toolbox.

Authors:  Chao Li; Chaozhe Han; Shao Duan; Ping Li; Israt S Alam; Zunyu Xiao
Journal:  J Nucl Med       Date:  2021-12-09       Impact factor: 10.057

Review 4.  Fundamentals and developments in fluorescence-guided cancer surgery.

Authors:  J Sven D Mieog; Friso B Achterberg; Aimen Zlitni; Merlijn Hutteman; Jacobus Burggraaf; Rutger-Jan Swijnenburg; Sylvain Gioux; Alexander L Vahrmeijer
Journal:  Nat Rev Clin Oncol       Date:  2021-09-07       Impact factor: 66.675

Review 5.  Immuno-Imaging (PET/SPECT)-Quo Vadis?

Authors:  Carsten S Kramer; Antonia Dimitrakopoulou-Strauss
Journal:  Molecules       Date:  2022-05-23       Impact factor: 4.927

6.  ImmunoPET: Concept, Design, and Applications.

Authors:  Weijun Wei; Zachary T Rosenkrans; Jianjun Liu; Gang Huang; Quan-Yong Luo; Weibo Cai
Journal:  Chem Rev       Date:  2020-03-23       Impact factor: 60.622

Review 7.  Assessing the interactions between radiotherapy and antitumour immunity.

Authors:  Clemens Grassberger; Susannah G Ellsworth; Moses Q Wilks; Florence K Keane; Jay S Loeffler
Journal:  Nat Rev Clin Oncol       Date:  2019-06-26       Impact factor: 66.675

Review 8.  Enzymatic Methods for the Site-Specific Radiolabeling of Targeting Proteins.

Authors:  Cristina Bolzati; Barbara Spolaore
Journal:  Molecules       Date:  2021-06-08       Impact factor: 4.411

9.  ERK Inhibition Improves Anti-PD-L1 Immune Checkpoint Blockade in Preclinical Pancreatic Ductal Adenocarcinoma.

Authors:  Kelly E Henry; Kyeara N Mack; Veronica L Nagle; Mike Cornejo; Adam O Michel; Ian L Fox; Maria Davydova; Thomas R Dilling; Nagavarakishore Pillarsetty; Jason S Lewis
Journal:  Mol Cancer Ther       Date:  2021-08-04       Impact factor: 6.261

Review 10.  Synergies between therapeutic ultrasound, gene therapy and immunotherapy in cancer treatment.

Authors:  Nisi Zhang; James Wang; Josquin Foiret; Zhifei Dai; Katherine W Ferrara
Journal:  Adv Drug Deliv Rev       Date:  2021-07-30       Impact factor: 15.470

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.